Mutations in hemG Mediate Resistance to Salicylidene Acylhydrazides, Demonstrating a Novel Link between Protoporphyrinogen Oxidase (HemG) and Chlamydia trachomatis Infectivity

Keywords

Biology, Protoporphyrinogen oxidase, Infectivity, Chlamydia trachomatis, Chlamydiaceae

References

• Metalloprotease Inhibitors GM6001 and TAPI-0 Inhibit the Obligate Intracellular Human Pathogen Chlamydia trachomatis by Targeting Peptide Deformylase of the Bacterium*Amit Balakrishnan, Bhairavi Patel, Stephan A. Sieber — 2006
• Type III secretion à la Chlamydia.Claudia Alejandra Troncoso, Analía Almirón — 2007
• Effector protein modulation of host cells: examples in the Chlamydia spp. arsenal.Javier Garduño — 2009
• Preliminary pharmacokinetics of the bacterial virulence inhibitor n'-(3,5-dibromo-2-hydroxy-benzylidenene)-nicotinic Acid hydrazide.Tofeeq Ur-Rehman, Roland Nordfelth, Anders Blomgren — 2012
• Spatial constraints within the chlamydial host cell inclusion predict interrupted development and persistenceAlexander Hoare, Peter Timms, Patrik M. Bavoil — 2008
• A whole genome view of prokaryotic haem biosynthesis.Heather R. Panek, Mark R. O’Brian — 2002
• Response of Chlamydia trachomatis serovar E to iron restriction in vitro and evidence for iron-regulated chlamydial proteinsJane E. Raulston — 1997
• Salicylidene acylhydrazide-mediated inhibition of type III secretion system-1 in Salmonella enterica serovar Typhimurium is associated with iron restriction and can be reversed by free iron.Abigail N. Layton, Debra L. Hudson, Arthur R. Thompson — 2010
• Structural insight into unique properties of protoporphyrinogen oxidase from Bacillus subtilis.Xiaohong Qin, Lu Sun, Xin Wen — 2010
• Targeting bacterial virulence: inhibitors of type III secretion in Yersinia.Anna M. Kauppi, Roland Nordfelth, Hanna Uvell — 2003
• Actin Recruitment to the Chlamydia Inclusion Is Spatiotemporally Regulated by a Mechanism That Requires Host and Bacterial FactorsElizabeth Chin, Kelly R. Kirker, Meghan Zuck — 2012
• Statistical molecular design of a focused salicylidene acylhydrazide library and multivariate QSAR of inhibition of type III secretion in the Gram-negative bacterium Yersinia.Markus K. Dahlgren, Caroline E. Zetterström, Åsa Gylfe — 2010
• Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycleKaterina Wolf, Helen J. Betts, Blandine Chellas-Géry — 2006
• Virulence blockers as alternatives to antibiotics: type III secretion inhibitors against Gram‐negative bacteriaP. De Keyser, Mikael Elofsson, Sune Rosell — 2008
• The biochemistry of heme biosynthesis.Ilka U. Heinemann, Martina Jahn, Dieter Jahn — 2008
• Protein delivery into eukaryotic cells by type III secretion machinesJorge E. Galán, Hans Wolf‐Watz — 2006
• Crystal Structure of Protoporphyrinogen Oxidase from Myxococcus Xanthus and its Complex with the Inhibitor AcifluorfenHazel Corradi, Anne V. Corrigall, Ester Boix — 2006
• Heme biosynthesis is coupled to electron transport chains for energy generationKalle Möbius, Rodrigo Arias-Cartín, Daniela Breckau — 2010
• Resolution of Holliday junctions in vitro requires the Escherichia coli ruvC gene product.Bernadette Connolly, Carol A. Parsons, Fiona E. Benson — 1991
• A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatisSandra Muschiol, Leslie Bailey, Åsa Gylfe — 2006

Cited by

• The Chlamydia trachomatis type III secretion substrates CT142, CT143, and CT144 are secreted into the lumen of the inclusionIzzah Suhaila, Abu Bakar — 2017
• GrgA as a potential target of selective antichlamydialsIsmael Ojeda Castillo — 2018
• Design, synthesis and evaluation of novel polypharmacological antichlamydial agents.Naresh Sunduru, Olli Salin, Åsa Gylfe — 2015
• Application of β-Lactamase Reporter Fusions as an Indicator of Effector Protein Secretion during Infections with the Obligate Intracellular Pathogen Chlamydia trachomatisKonrad Mueller, Kenneth A. Fields — 2015
• Chlamydia trachomatis In Vivo to In Vitro Transition Reveals Mechanisms of Phase Variation and Down-Regulation of Virulence FactorsVítor Borges, Miguel Pinheiro, Minia Antelo-Varela — 2015
• Expansion of the Chlamydia trachomatis inclusion does not require bacterial replication.Patrik Engström, Malin Bergström, Astrid Carolina Alfaro — 2015
• Whole-genome enrichment and sequencing of Chlamydia trachomatisdirectly from clinical samplesMette T. Christiansen, Amanda C. Brown, Samit Kundu — 2014
• The Type III Secretion System (T3SS) of Chlamydophila psittaci Is Involved in the Host Inflammatory Response by Activating the JNK/ERK Signaling PathwayQing‐zhi He, Huaicai Zeng, Yan Huang — 2015
• N-Acylated Derivatives of Sulfamethoxazole and Sulfafurazole Inhibit Intracellular Growth of Chlamydia trachomatisSania Marwaha, Hanna Uvell, Olli Salin — 2014
• Identification of in vivo-induced bacterial protein antigens during calf infection with Chlamydia psittaci.Julia rer. nat. Kästner, Hans Peter Saluz, F. Hänel — 2015
• Targeting the type III secretion system to treat bacterial infectionsNatalie C. Marshall, B. Brett Finlay — 2014
• The Bacterial Type III Secretion System as a Target for Developing New AntibioticsAndrew C. McShan, Roberto N. De Guzman — 2015
• A 2-Pyridone-Amide Inhibitor Targets the Glucose Metabolism Pathway of Chlamydia trachomatisPatrik Engström, K. Syam Krishnan, Bidong D. Ngyuen — 2014
• Benzylidene Acylhydrazides Inhibit Chlamydial Growth in a Type III Secretion- and Iron Chelation-Independent MannerXiaofeng Bao, Åsa Gylfe, Gail L. Sturdevant — 2014
• Influence of chelation strength and bacterial uptake of gallium salicylidene acylhydrazide on biofilm formation and virulence of Pseudomonas aeruginosa.Shoghik Hakobyan, Olena Rzhepishevska, Erik Björn — 2016
• Approaches targeting the type III secretion system to treat or prevent bacterial infectionsNuno Charro, Luı́s Jaime Mota — 2015
• New Frontiers in Type III Secretion Biology: the Chlamydia PerspectiveKonrad Mueller, Gregory V. Plano, Kenneth A. Fields — 2013
• Evolutionary dynamics of Chlamydia trachomatis genome and identification of molecular patterns of hypothetical protein coding genesV. Borges — 2015
• Salicylidene Acylhydrazides and Hydroxyquinolines Act as Inhibitors of Type Three Secretion Systems in Pseudomonas aeruginosa by Distinct MechanismsAhalieyah Anantharajah, Julien M. Buyck, Charlotta Sundin — 2017
• N-Acylated Derivatives of Sulfamethoxazole Block Chlamydia Fatty Acid Synthesis and Interact with FabFSergio A. Mojica, Olli Salin, Robert J. Bastidas — 2017

Related papers

• Comparative evaluation of detection assays for Chlamydia trachomatisRobert J. Warren, Brian Dwyer, M Plackett — 1991
• Waddlia chondrophila and Chlamydia trachomatis antibodies in screening infertile women for tubal pathology.Stephan P. Verweij, Carole Kebbi‐Beghdadi, J. A. Land — 2015
• Comparison of the Syva Microtrak enzyme immunoassay and Abbott Chlamydiazyme in the detection of chlamydial infections in women.Margaret Olsen, Anthony R. Sambol, Virginia A. Bohnert — 1995
• TestPack Chlamydia, a new rapid assay for the direct detection of Chlamydia trachomatisPaul F. Coleman, Vincent A. Varitek, Isa K. Mushahwar — 1989
• Detection of Chlamydia trachomatis by the Gen-Probe AMPLIFIED Chlamydia Trachomatis Assay (AMP CT) in Urine Specimens from Men and Women and Endocervical Specimens from WomenKimberly A. Crotchfelt, Barbara Pare, Charlotte A. Gaydos — 1998
• Performance of Chlamydia trachomatis OmcB Enzyme-Linked Immunosorbent Assay in Serodiagnosis of Chlamydia trachomatis Infection in WomenKanupriya Gupta, LaDraka’ T. Brown, Rakesh K. Bakshi — 2018
• Identification of Chlamydia trachomatis by direct immunofluorescence applied in specimens originating in remote areasTrevor Williams, A. C. Maniar, R C Brunham — 1985
• Effect of patient characteristics on performance of an enzyme immunoassay for detecting cervical Chlamydia trachomatis infectionLaurence S. Magder, K C Klontz, L H Bush — 1990
• Detection of Chlamydia trachomatis infections in women by Amplicor PCR: comparison of diagnostic performance with urine and cervical specimensRafael Pasternack, Pauli Vuorinen, A Kuukankorpi — 1996